AR021037A1 - Derivados aromaticos y sus relativos complejos de hierro aptos para el uso como agentes normalizantes del nivel de hierro en el organismo - Google Patents

Derivados aromaticos y sus relativos complejos de hierro aptos para el uso como agentes normalizantes del nivel de hierro en el organismo

Info

Publication number
AR021037A1
AR021037A1 ARP990105492A ARP990105492A AR021037A1 AR 021037 A1 AR021037 A1 AR 021037A1 AR P990105492 A ARP990105492 A AR P990105492A AR P990105492 A ARP990105492 A AR P990105492A AR 021037 A1 AR021037 A1 AR 021037A1
Authority
AR
Argentina
Prior art keywords
iron
relatives
organism
aromatic derivatives
complex
Prior art date
Application number
ARP990105492A
Other languages
English (en)
Original Assignee
Medidom S A Swis Joint Stock Co Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom S A Swis Joint Stock Co Lab filed Critical Medidom S A Swis Joint Stock Co Lab
Publication of AR021037A1 publication Critical patent/AR021037A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)

Abstract

Derivados de la formula (1), donde: R1 es igual a -CH(R3)-C(=O)-CH2-R4 donde R3 y R4 se seleccionan entre H y OH, con la condicion de que no seancontemporáneamente H, y R2 es igual a H; o bien R1 y R2 tomados en conjunto son -C(OH)=C(R5)-, donde R5e s seleccionado entre CH3 y (CH2)5OH, suscorrespondientes complejos de hierro, y su utilizacion para la preparacion de composiciones farmacéuticas utiles para la normalizacion del nivel de hierro enel organismo.
ARP990105492A 1998-11-02 1999-10-29 Derivados aromaticos y sus relativos complejos de hierro aptos para el uso como agentes normalizantes del nivel de hierro en el organismo AR021037A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002350A IT1303688B1 (it) 1998-11-02 1998-11-02 Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo.

Publications (1)

Publication Number Publication Date
AR021037A1 true AR021037A1 (es) 2002-06-12

Family

ID=11380986

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105492A AR021037A1 (es) 1998-11-02 1999-10-29 Derivados aromaticos y sus relativos complejos de hierro aptos para el uso como agentes normalizantes del nivel de hierro en el organismo

Country Status (17)

Country Link
US (1) US6455578B1 (es)
EP (1) EP1124814B1 (es)
JP (1) JP2002528539A (es)
AR (1) AR021037A1 (es)
AT (1) ATE229947T1 (es)
AU (1) AU756726B2 (es)
BR (1) BR9914863A (es)
CA (1) CA2348380C (es)
CZ (1) CZ299542B6 (es)
DE (1) DE69904635T2 (es)
DK (1) DK1124814T3 (es)
ES (1) ES2189537T3 (es)
IL (2) IL142813A0 (es)
IT (1) IT1303688B1 (es)
PL (1) PL198826B1 (es)
SK (1) SK286308B6 (es)
WO (1) WO2000026205A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007233829A1 (en) * 2006-03-29 2007-10-11 Basf Se Use of strobilurins for treating malfunctions of the iron metabolism

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122200A (en) * 1974-11-20 1978-10-24 Lipha, Lyonnaise Industrielle Pharmaceutique 6',2-(2'Arylchromonyl) propionic acids, and analgesic and anti-inflammatory derivatives thereof
EP0017332B1 (en) * 1979-03-20 1985-07-31 FISONS plc Pharmaceutical heterocyclic compounds, processes for their preparation and compositions containing them
EP0346279A1 (de) * 1988-06-06 1989-12-13 Ciba-Geigy Ag Propan-1,3-dionderivate und deren Verwendung als Stabilisatoren für chlorhaltige Polymerisate

Also Published As

Publication number Publication date
IL142813A0 (en) 2002-03-10
ATE229947T1 (de) 2003-01-15
WO2000026205A1 (en) 2000-05-11
EP1124814B1 (en) 2002-12-18
IL142813A (en) 2006-12-10
PL198826B1 (pl) 2008-07-31
PL347940A1 (en) 2002-04-22
JP2002528539A (ja) 2002-09-03
EP1124814A1 (en) 2001-08-22
CZ20011461A3 (cs) 2001-08-15
SK5562001A3 (en) 2001-09-11
CZ299542B6 (cs) 2008-08-27
BR9914863A (pt) 2001-07-03
DE69904635D1 (de) 2003-01-30
ITMI982350A1 (it) 2000-05-02
ES2189537T3 (es) 2003-07-01
DE69904635T2 (de) 2003-10-02
AU1157300A (en) 2000-05-22
AU756726B2 (en) 2003-01-23
DK1124814T3 (da) 2003-04-14
SK286308B6 (en) 2008-07-07
US6455578B1 (en) 2002-09-24
CA2348380C (en) 2009-02-17
IT1303688B1 (it) 2001-02-23
CA2348380A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
SV1999000118A (es) Nuevos derivados de pirazol substituidos ref. lea 33188-sv
ES2122043T3 (es) Nuevos derivados sustituidos del pirazol, procedimientos para su preparacion y su empleo como herbicidas.
DE3761562D1 (de) Taxal-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
DE59009351D1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
ATE40819T1 (de) 4-vinylbenzoesaeure-derivate, ihre herstellung und verwendung als arzneimittel und ligande.
AR025739A1 (es) Nuevos derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina
ATE90345T1 (de) Bis-naphthalimide, ihre herstellung und verwendung.
EP0939627A4 (en) PENTAFLUOROBENZENE SULFAMIDES AND THE LIKE
ATE45579T1 (de) Diazabicyclo-(3,3,1)-nonane.
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
TR200402083T2 (tr) Parkinson hastalığı, adhd ve mikroadenomların tedavisi için ilaçlar
ATE10804T1 (de) Ein diphenylhydantoin-derivat enthaltende pharmazeutische zusammensetzung, verwendete derivate und ihre herstellung.
ATE115541T1 (de) Benzyloxyphenylderivate.
DE59001281D1 (de) Oxidierte diphenylheteroalkane, ihre herstellung und verwendung.
ATE53377T1 (de) 1-substituierte tetralinderivate, ihre herstellung und verwendung.
ATE130848T1 (de) Neue retinoide, ihre herstellung und verwendung für heilmittel.
ATE108176T1 (de) Beta-phenylisoserinderivate, ihre herstellung und ihre anwendung.
AR021037A1 (es) Derivados aromaticos y sus relativos complejos de hierro aptos para el uso como agentes normalizantes del nivel de hierro en el organismo
DE3785505D1 (de) Syntheseprodukte aus schwefel oder nichtschwefelhaltigen aminosaeuren mit pregnanderivaten, ihre herstellung und ihre anwendung.
ATE70060T1 (de) Neue tetrahydro-benzothiazole, ihre herstellung und verwendung.
YU17999A (sh) Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu
UY27372A1 (es) Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados
ATE155791T1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
ATE54446T1 (de) Substituierte azabicycloheptane, ihre verwendung, pharmazeutische praeparate, welche diese verbindungen enthalten, und verfahren zur herstellung dieser verbindungen.

Legal Events

Date Code Title Description
FB Suspension of granting procedure